SMG1P1

Across TCGA pan-cancer cohorts, SMG1P1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SMG1P1 data layer compared with 21 for mass-spec protein.

The strongest signal is observed in testicular germ cell tumors (TGCT), where higher SMG1P1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated SMG1P1 expression acts as an unfavorable survival marker.

TGCT and SKCM are the cancer types where SMG1P1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
TGCT	OS	Median	All	0.069	0.968	<.001	12	view →
SKCM	OS	Median	All	0.233	0.787	.004	12	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SMG1P1–TGCT (OS)

Open the TGCT breakdown →